Phase 1/2 Study of AGN-241622 in Healthy Participants and Participants With Presbyopia
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Presbyopia
- Type
- Interventional
- Phase
- Phase 1Phase 2
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Double (Participant, Investigator)Masking Description: Double-masked and Single-masked. One cohort is single-masked. All other cohorts are Double-Masked.Primary Purpose: Treatment
Participation Requirements
- Age
- Between 40 years and 65 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04403763
- Collaborators
- Not Provided
- Investigators
- Study Director: Michelle Chen Allergan Study Director: Wayne Chen, PharmD Allergan
Get Well Soon